HSPG2 and fungal infectious disease: Also in the case of PLC, PLEVA, LyP, and Mycosis Fungoides we have progressively used UVA1 phototherapy to only patients who were not candidates for, or not responsive to, standard NB-UVB phototherapy (16–19), PUVA therapy or drug therapies.